A prospective cohort study on effects of gemigliptin on cardiovascular outcomes in patients with type 2 diabetes (OPTIMUS study)

This study was performed to evaluate the long-term cardiovascular safety of gemigliptin in patients with type 2 diabetes mellitus (T2DM). After screening, eligible patients with T2DM were enrolled, received gemigliptin, and were followed up for a median of 2.50 years. The primary outcome was a compo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eun Heui, Kim, Sang Soo, Kim, Dong Jun, Choi, Young Sik, Lee, Chang Won, Ku, Bon Jeong, Cha, Kwang Soo, Song, Kee Ho, Kim, Dae Kyeong, Kim, In Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642439/
https://www.ncbi.nlm.nih.gov/pubmed/33149182
http://dx.doi.org/10.1038/s41598-020-75594-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642439/
https://www.ncbi.nlm.nih.gov/pubmed/33149182
http://dx.doi.org/10.1038/s41598-020-75594-5

Ejemplares similares